Cargando…

Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1

It is acknowledged that vaccines remain the best hope for eliminating the HIV-1 epidemic. However, the failure to produce effective vaccine immunogens and the inability of conventional delivery strategies to elicit the desired immune responses remains a central theme and has ultimately led to a sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yong, Wijewardhana, Chanuka, Mann, Jamie F. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835502/ https://www.ncbi.nlm.nih.gov/pubmed/29541072 http://dx.doi.org/10.3389/fimmu.2018.00345

Ejemplares similares

A heterogeneous human immunodeficiency virus-like particle (VLP) formulation produced by a novel vector system
por: Pankrac, Joshua, et al.
Publicado: (2018)

Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines
por: Chen, Chun-Wei, et al.
Publicado: (2020)

Platforms, advances, and technical challenges in virus-like particles-based vaccines
por: Gupta, Reeshu, et al.
Publicado: (2023)

Virus like particles as a platform for cancer vaccine development
por: Ong, Hui Kian, et al.
Publicado: (2017)

Adjusted Particle Size Eliminates the Need of Linkage of Antigen and Adjuvants for Appropriated T Cell Responses in Virus-Like Particle-Based Vaccines
por: Gomes, Ariane C., et al.
Publicado: (2017)

6-Valent Virus-Like Particle-Based Vaccine Induced Potent and Sustained Immunity Against Noroviruses in Mice
por: Hou, Wenli, et al.
Publicado: (2022)

Polymeric Pathogen-Like Particles-Based Combination Adjuvants Elicit Potent Mucosal T Cell Immunity to Influenza A Virus
por: Kingstad-Bakke, Brock, et al.
Publicado: (2021)

Virus‐like particles for vaccination against cancer
por: Mohsen, Mona O., et al.
Publicado: (2019)

Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
por: Zhou, Fangbin, et al.
Publicado: (2023)

Single Dose of Consensus Hemagglutinin-Based Virus-Like Particles Vaccine Protects Chickens against Divergent H5 Subtype Influenza Viruses
por: Wu, Peipei, et al.
Publicado: (2017)

Immunogenicity of a Virus-Like-Particle Vaccine Containing Multiple Antigenic Epitopes of Toxoplasma gondii Against Acute and Chronic Toxoplasmosis in Mice
por: Guo, Jingjing, et al.
Publicado: (2019)

A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model
por: Pliasas, Vasilis C., et al.
Publicado: (2022)

Current Advances in Virus-Like Particles as a Vaccination Approach against HIV Infection
por: Zhao, Chongbo, et al.
Publicado: (2016)

Suitability of potyviral recombinant virus-like particles bearing a complete food allergen for immunotherapy vaccines
por: Pazos-Castro, Diego, et al.
Publicado: (2022)

Supplementation of H7N9 Virus-Like Particle Vaccine With Recombinant Epitope Antigen Confers Full Protection Against Antigenically Divergent H7N9 Virus in Chickens
por: Kong, Dexin, et al.
Publicado: (2022)

Production of virus-like particles for vaccines
por: Fuenmayor, J., et al.
Publicado: (2017)

Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection
por: Corthésy, Blaise, et al.
Publicado: (2018)

Corrigendum: Suitability of potyviral recombinant virus-like particles bearing a complete food allergen for immunotherapy vaccines
por: Pazos-Castro, Diego, et al.
Publicado: (2023)

Virus like particle-based vaccines against emerging infectious disease viruses
por: Liu, Jinliang, et al.
Publicado: (2016)

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2022)

Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
por: Perotti, Michela, et al.
Publicado: (2019)

Virus-Like Particle Based Vaccines Elicit Neutralizing Antibodies against the HIV-1 Fusion Peptide
por: Mogus, Alemu Tekewe, et al.
Publicado: (2020)

Parainfluenza Virus 5 Priming Followed by SIV/HIV Virus-Like-Particle Boosting Induces Potent and Durable Immune Responses in Nonhuman Primates
por: Xiao, Peng, et al.
Publicado: (2021)

Activation of NLRP3 Inflammasome by Virus-Like Particles of Human Polyomaviruses in Macrophages
por: Lučiūnaitė, Asta, et al.
Publicado: (2022)

A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques
por: Volkmann, Ariane, et al.
Publicado: (2022)

Partial Protection against Porcine Influenza A Virus by a Hemagglutinin-Expressing Virus Replicon Particle Vaccine in the Absence of Neutralizing Antibodies
por: Ricklin, Meret E., et al.
Publicado: (2016)

Virus-Like Particle and Nanoparticle Vaccines
por: Kanekiyo, M., et al.
Publicado: (2017)

Special Issue “Virus-Like Particle Vaccines”
por: Vogel, Monique, et al.
Publicado: (2020)

Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus
por: Mazalovska, Milena, et al.
Publicado: (2020)

Virus-Like Particle Systems for Vaccine Development against Viruses in the Flaviviridae Family
por: Wong, Shu Hui, et al.
Publicado: (2019)

Bacterium-Like Particles for Efficient Immune Stimulation of Existing Vaccines and New Subunit Vaccines in Mucosal Applications
por: Van Braeckel-Budimir, Natalija, et al.
Publicado: (2013)

Novel Virus-Like Particle Vaccine Encoding the Circumsporozoite Protein of Plasmodium falciparum Is Immunogenic and Induces Functional Antibody Responses in Mice
por: Kurtovic, Liriye, et al.
Publicado: (2021)

Vaccine Potential of Nipah Virus-Like Particles
por: Walpita, Pramila, et al.
Publicado: (2011)

TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle Immunization
por: Chang, Xinyue, et al.
Publicado: (2022)

Erratum: Virus-like particles are efficient tools for boosting mRNA-induced antibodies
Publicado: (2023)

Promotion of Cellular and Humoral Immunity against Foot-and-Mouth Disease Virus by Immunization with Virus-Like Particles Encapsulated in Monophosphoryl Lipid A and Liposomes
por: Kim, Woo Sik, et al.
Publicado: (2020)

All the small things: How virus‐like particles and liposomes modulate allergic immune responses
por: Kratzer, Bernhard, et al.
Publicado: (2019)

Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice
por: Kim, Yu-Jin, et al.
Publicado: (2017)

Pigs Immunized with the Virus-like Particle Vaccine Are Protected against the Hepatitis E-3 Virus
por: Go, Hyeon-Jeong, et al.
Publicado: (2021)

Virus-like Particle Vaccines and Platforms for Vaccine Development
por: Kheirvari, Milad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4g84lkibie5e18d1tq8rqc2lgv